Oncology Market in India 2025-2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	178 Pages	TechNavio	February, 2025	INF19659194

Best Price Guarantee
Price	from $2,500
Length	178 Pages
Publisher	TechNavio
Published Date	February, 2025
SKU	INF19659194

Oncology Market In India 2025-2029

The oncology market in India is forecasted to grow by USD 2018.9 million during 2024-2029, accelerating at a CAGR of 19.8% during the forecast period. The report on the oncology market in India provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased prevalence of cancer, growing investment for cost-cutting in drug discovery and development, and increasing demand for precision medicine.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's oncology market in India is segmented as below:

By Type

Cancer treatment
Cancer diagnostics

By End-user

Hospitals
Diagnostic laboratories
Diagnostic imaging centers
Others

By Geographical Landscape

Asia

This study identifies the rise in research and development for developing diagnostic devices as one of the prime reasons driving the oncology market in India growth during the next few years. Also, growing adoption of immunotherapy and growing adoption of robotic surgeries in oncology treatments will lead to sizable demand in the market.

The report on the oncology market in India covers the following areas:

Oncology Market in India sizing
Oncology Market in India forecast
Oncology Market in India industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading oncology market in India vendors that include 3M Co., Abbott Laboratories, Alkem Laboratories Ltd., AstraZeneca PLC, Baxter International Inc., Bristol Myers Squibb Co., Cipla Inc., F. Hoffmann La Roche Ltd., GE Healthcare Technologies Inc., Glenmark Pharmaceuticals Ltd., Lupin Ltd., Medtronic PLC, Merck and Co. Inc., Natco Pharma Ltd., Novartis AG, Poly Medicure Ltd., Siemens Healthineers AG, Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., and Zydus Lifesciences Ltd.. Also, the oncology market in India analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Executive Summary
- Market overview
  - Table Executive Summary - Data Table on Market Overview
Technavio Analysis
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Criticality of inputs and Factors of differentiation
- Factors of disruption
- Impact of drivers and challenges
Market Landscape
- Market ecosystem
  - Table Data Table on - Parent Market
- Market characteristics
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2024
- Market outlook: Forecast for 2024-2029
  - Table Data Table on India - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on India: Year-over-year growth 2024-2029 (%)
Historic Market Size
- Oncology Market in India 2019 - 2023
  - Table Historic Market Size - Data Table on Oncology Market in India 2019 - 2023 ($ million)
- Type segment analysis 2019 - 2023
- End-user segment analysis 2019 - 2023
- Disease Type segment analysis 2019 - 2023
Qualitative Analysis
- Impact of AI in oncology market in India
Five Forces Analysis
- Five forces summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Type
- Market segments
  - Table Data Table on Type - Market share 2024-2029 (%)
- Comparison by Type
  - Table Data Table on Comparison by Type
- Cancer treatment - Market size and forecast 2024-2029
  - Table Data Table on Cancer treatment - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Cancer treatment - Year-over-year growth 2024-2029 (%)
- Cancer diagnostics - Market size and forecast 2024-2029
  - Table Data Table on Cancer diagnostics - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Cancer diagnostics - Year-over-year growth 2024-2029 (%)
- Market opportunity by Type
  - Table Data Table on Market opportunity by Type ($ million)
Market Segmentation by End-user
- Market segments
  - Table Data Table on End-user - Market share 2024-2029 (%)
- Comparison by End-user
  - Table Data Table on Comparison by End-user
- Hospitals - Market size and forecast 2024-2029
  - Table Data Table on Hospitals - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
- Diagnostic laboratories - Market size and forecast 2024-2029
  - Table Data Table on Diagnostic laboratories - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Diagnostic laboratories - Year-over-year growth 2024-2029 (%)
- Diagnostic imaging centers - Market size and forecast 2024-2029
  - Table Data Table on Diagnostic imaging centers - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Diagnostic imaging centers - Year-over-year growth 2024-2029 (%)
- Others - Market size and forecast 2024-2029
  - Table Data Table on Others - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Others - Year-over-year growth 2024-2029 (%)
- Market opportunity by End-user
  - Table Data Table on Market opportunity by End-user ($ million)
Market Segmentation by Disease Type
- Market segments
  - Table Data Table on Disease Type - Market share 2024-2029 (%)
- Comparison by Disease Type
  - Table Data Table on Comparison by Disease Type
- Breast cancer - Market size and forecast 2024-2029
  - Table Data Table on Breast cancer - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Breast cancer - Year-over-year growth 2024-2029 (%)
- Lung cancer - Market size and forecast 2024-2029
  - Table Data Table on Lung cancer - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Lung cancer - Year-over-year growth 2024-2029 (%)
- Blood cancer - Market size and forecast 2024-2029
  - Table Data Table on Blood cancer - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Blood cancer - Year-over-year growth 2024-2029 (%)
- Colorectal cancer - Market size and forecast 2024-2029
  - Table Data Table on Colorectal cancer - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Colorectal cancer - Year-over-year growth 2024-2029 (%)
- Others - Market size and forecast 2024-2029
  - Table Data Table on Others - Market size and forecast 2024-2029 ($ million)
  - Table Data Table on Others - Year-over-year growth 2024-2029 (%)
- Market opportunity by Disease Type
  - Table Data Table on Market opportunity by Disease Type ($ million)
Customer Landscape
- Customer landscape overview
Drivers, Challenges, and Opportunity/Restraints
- Market drivers
  - Increased prevalence of cancer
  - Growing investment for cost-cutting in drug discovery and development
  - Increasing demand for precision medicine
- Market challenges
  - High cost of products for treatment of cancer
  - Side effects associated with chemotherapy
  - Lack of adequate healthcare infrastructure
- Impact of drivers and challenges
- Market opportunities/restraints
  - Rise in research and development for developing diagnostic devices
  - Growing adoption of immunotherapy
  - Growing adoption of robotic surgeries in oncology treatments
Competitive Landscape
- Overview
- Competitive Landscape
- Landscape disruption
- Industry risks
Competitive Analysis
- Companies profiled
- Company ranking index
- Market positioning of companies
- Abbott Laboratories
- Alkem Laboratories Ltd.
- AstraZeneca Plc
- Bristol Myers Squibb Co.
- Cipla Inc.
- F. Hoffmann La Roche Ltd.
- GE Healthcare Technologies Inc.
- Glenmark Pharmaceuticals Ltd.
- Lupin Ltd.
- Medtronic Plc
- Merck and Co. Inc.
- Natco Pharma Ltd.
- Siemens Healthineers AG
- Sun Pharmaceutical Industries Ltd.
- Zydus Lifesciences Ltd.
Appendix
- Scope of the report
  - Market definition
  - Objectives
  - Notes and caveats
- Inclusions and exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Data procurement
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations